Hainan Poly (China) Today

300630 Stock   6.81  0.26  3.97%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 30

 
High
 
Low
Below Average
Hainan Poly is trading at 6.81 as of the 2nd of January 2025, a 3.97 percent increase since the beginning of the trading day. The stock's open price was 6.55. Hainan Poly has about a 30 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 13th of January 2023 and ending today, the 2nd of January 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Hainan Poly is entity of China. It is traded as Stock on SHE exchange. The company has 451.78 M outstanding shares. More on Hainan Poly Pharm

Moving together with Hainan Stock

  0.8600048 Poly Real EstatePairCorr
  0.84000002 China VankePairCorr
  0.7001979 China Merchants ShekouPairCorr
  0.86600325 Huafa IndustrialPairCorr

Moving against Hainan Stock

  0.6603662 Keli Sensing TechnologyPairCorr

Hainan Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Hainan Poly's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Hainan Poly or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman GMMin Fan
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors)
Hainan Poly's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Hainan Poly's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Hainan Poly can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Hainan Poly's financial leverage. It provides some insight into what part of Hainan Poly's total assets is financed by creditors.
Liquidity
Hainan Poly cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Hainan Poly Pharm has accumulated 384.61 M in total debt. Debt can assist Hainan Poly until it has trouble settling it off, either with new capital or with free cash flow. So, Hainan Poly's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hainan Poly Pharm sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hainan to invest in growth at high rates of return. When we think about Hainan Poly's use of debt, we should always consider it together with cash and equity.

Change To Inventory

(32.13 Million)
Hainan Poly Pharm (300630) is traded on Shenzhen Stock Exchange in China and employs 1,565 people. Hainan Poly is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.11 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hainan Poly's market, we take the total number of its shares issued and multiply it by Hainan Poly's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hainan Poly Pharm operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 451.78 M outstanding shares. Hainan Poly generates positive cash flow from operations, but has no cash available
Check Hainan Poly Probability Of Bankruptcy
Ownership Allocation
Hainan Poly Pharm has a total of 451.78 Million outstanding shares. Hainan Poly secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Hainan Ownership Details

Hainan Poly Pharm Risk Profiles

Although Hainan Poly's alpha and beta are two of the key measurements used to evaluate Hainan Poly's performance over the market, the standard measures of volatility play an important role as well.

Hainan Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Hainan Poly without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module

Hainan Poly Corporate Management

Elected by the shareholders, the Hainan Poly's board of directors comprises two types of representatives: Hainan Poly inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hainan. The board's role is to monitor Hainan Poly's management team and ensure that shareholders' interests are well served. Hainan Poly's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hainan Poly's outside directors are responsible for providing unbiased perspectives on the board's policies.
Zhou MaoSecretary GMProfile
Yinkui ZouDeputy ManagerProfile
Xu ZhaoSecurities RepresentativeProfile
Xuelai ZhouDeputy ManagerProfile

Other Information on Investing in Hainan Stock

Hainan Poly financial ratios help investors to determine whether Hainan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hainan with respect to the benefits of owning Hainan Poly security.